NAMPT and neoplasm: We elected to use STF-118804 for our in-vivo experimentation as it showed promising results as a NAMPT-specific inhibitor in-vitro, has not been explored as thoroughly in the literature, and has been shown to sensitize tumor cells to chemotherapeutic agents (25, 30).